Cancer

Health Elizabeth Cooney

With cancer expected to surge 77% worldwide by 2050, an oncologist weighs in on global disparities

Health Angus Chen

We’re naming cancers all wrong, oncology leader says

The Readout Meghana Keshavan

STAT Plus: 23andMe breach targeted Chinese, Jewish populations

The Readout Damian Garde

STAT Plus: Eli Lilly overtakes Tesla in market value

Health Felice J. Freyer — Boston Globe

STAT Plus: Early detection of pancreatic cancer could get a boost from AI that identifies people at higher risk

Health Annalisa Merelli

HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14

The Readout Damian Garde

STAT Plus: Another step toward new drugs for Parkinson’s

Health Rosa Furneaux and Laura Margottini — TBIJ

‘The response defies belief’: Year of inaction leaves children at risk from bad cancer drugs

The Readout Damian Garde

STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

Health Annalisa Merelli

Mammograms are less effective for women with dense breast tissue. Medical experts disagree on what to do about it

Biotech Matthew Herper

STAT Plus: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs

Pharmalot Ed Silverman

STAT Plus: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property

In the Lab Jonathan Wosen and Angus Chen

STAT Plus: Dana-Farber cancer researchers moving to retract one paper, correct others in broad investigation of manipulated data

Health tech Lizzy Lawrence

STAT Plus: FDA clears AI skin cancer detector for primary care doctors to use

In the Lab Angus Chen

STAT Plus: Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it

The Readout Meghana Keshavan

STAT Plus: The four biotech stories you need to read this morning

Health Andrew Joseph

STAT Plus: U.K. sequencing study surfaces new findings about tumor DNA

Biotech Allison DeAngelis

STAT Plus: JPM 2024: FogPharma’s new CEO, Mathai Mammen, unveils ‘contrarian’ plan in oncology

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

Biotech Andrew Joseph

STAT Plus: The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma

Biotech Jason Mast

STAT Plus: Merck to acquire Harpoon Therapeutics for $680 million

Exclusive Matthew Herper

STAT Plus: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

The Readout Meghana Keshavan

STAT Plus: Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy?

Biotech Jonathan Wosen

STAT Plus: Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi

Biotech Adam Feuerstein

STAT Plus: Allogene to pursue new strategy for development of off-the-shelf cell therapy in blood cancer

Biotech Robert Weisman — Boston Globe

STAT Plus: Veteran biotech entrepreneur Harvey Berger to lead startup Kojin Therapeutics

Health Angus Chen

Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis

First Opinion Barron H. Lerner

Remembering Betty Rollin, who told her breast surgeon that post-operative appearance mattered to her — and other women

Biotech Damian Garde

STAT Plus: Bristol Myers will pay $4.1 billion for cancer startup RayzeBio